{
    "2019-01-08": [
        [
            {
                "time": "2019-01",
                "original_text": "2019年1月医药行业投资策略:“轻药重医”为正道,首推医疗器械板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "轻药重医",
                        "医疗器械"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01",
                "original_text": "医药行业周观点:2019推荐配置具备消费属性的医药标的,持续推荐长春高新、我武生物等标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周观点",
                        "消费属性",
                        "长春高新",
                        "我武生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}